CEO of DNA Analytics, Raymond J. Peterson, PhD, will be attending the BIO Partnering event at JPM Week in San Francisco next week. He is thrilled to represent DNA Analytics and share the power of the AccuMatch (TM) AI-powered solution that accelerates time to market and reduces the costs associated with the development of gene therapies, gene vaccines, and gene diagnostics. #genetics #moleculargenetics #dna #rna #sirna #mrna #oligo #partnering
DNA Analytics
生物技术研究
Prediction Made Better - Artificial Intelligence for Gene Therapy, Gene Vaccines, and Gene Diagnostics
关于我们
DNA Analytics is passionate about Prediction Made Better, using Artificial Intelligence for Gene Therapy, Gene Vaccines, and Gene Diagnostics. With our patent-pending AI algorithms -- ACCUMATCH (TM) -- we help scientists predict how strongly a chemical gene probe will match its target gene. This breakthrough has huge implications for the future of gene science, with applications for cancer, rare genetic disorders, as well as neurological, hepatological, and retinal diseases. Our platform enables scientists to model gene probe sequences, and through our statistical algorithms, to predict the melting temperature of the gene probe, to the gene. With melt temperature as the property most critical to gene probe success, we are then able to optimize the predictions out of 3.2 billion possible matches.
- 网站
-
https://dnaanalytics.com/
DNA Analytics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 类型
- 私人持股
- 领域
- gene therapy和gene research